Steven Neier

Steven is Principal at Binney Street Capital, as well as co-founder and Scientific Advisory Board member of SanaRx Biotherapeutics and NextRNA Therapeutics. He was a scientific consultant at QuantumCyte, Inc. while serving as a scientist at Dana-Farber Cancer Institute. Steven received his Ph.D. in immunology from Mayo Clinic.